Skip to main content

MoneyWorks4Me

Aurobindo Pharma informs about analysts presentation

24 Aug 2016 Evaluate

Aurobindo Pharma has submitted a copy of the presentation to the Investors/Analysts on the Unaudited Financial Results of the Company for the first quarter ended June 30, 2016.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..